Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Sponge on a String Detects Precursor to Esophageal Cancer

By LabMedica International staff writers
Posted on 28 Feb 2024

Esophageal cancer, which affects the food pipe, is a major cause of cancer deaths, ranking as the fourth highest in men and seventh in women. Its incidence is increasing, linked to risk factors like poor diet, smoking, alcohol use, and having a hiatus hernia. People with Barrett's esophagus are at a heightened risk for developing esophageal cancer. Endoscopy, a procedure involving a tiny camera inserted into the body, is used to diagnose various cancers, including those of the colon and stomach. Now, an innovative "sponge on a string" device coupled with a laboratory test can detect Barrett's esophagus, a precursor to esophageal cancer, offering a way to reduce the long waiting times for essential diagnostic tests.

The National Health Service (NHS, London, UK) conducted a trial of the "cytosponge," demonstrating its effectiveness in reducing the need for endoscopy. The cytosponge, a capsule about the size of a standard tablet, expands in the stomach once swallowed with water. It is then retrieved by pulling the attached string, and collecting cells for analysis to determine the presence of Barrett's esophagus. A simple antibody test then allows pathologists to easily spot signs of the precancerous condition. In a study involving 2,550 out of 8,500 patients tested with the cytosponge, it was found that 78% did not have Barrett's esophagus, allowing them to be monitored by their general practitioner instead of undergoing an endoscopy.

The trial also found that only 22% of those tested, who were at higher risk, required an endoscopic examination. This can not only speed up access to endoscopy for patients suspected of having higher-risk conditions but also significantly advance early cancer detection. The cytosponge is particularly appealing as it is quicker, less invasive, and more cost effective than traditional endoscopy. Experts believe this method could lead to earlier diagnosis of esophageal cancer, potentially reducing the need for late-stage treatments like chemotherapy and surgical removal of the esophagus.

Related Links:
NHS

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.